The ideals of New Yorkers and Trumpism appear to be in direct conflict with one another. So, if you think what’s happening in ...

Eli Lilly (LLY) heads into 2026 with GLP-1 pricing and competition risks; oral GLP-1 race heats up and downside looms.

The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald ...

Eli Lilly And Co (NYSE:LLY) and Novo Nordisk (NYSE:NVO), are reportedly being sued in Texas by compounding pharmacy Strive ...

A new obesity drug that Eli Lilly is researching but hasn't approved is turning up online, even though it's not supposed to be available.

Some women adopted non-Jewish identities to support the resistance. For most, though, it was simply a strategy for survival – ...

Eli Lilly (LLY) stock slips as the FDA decision on the company's obesity pill orforglipron is now due in April, which ...

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally ...

Calla Lily delivered one of the most emotional performances of ‘The Masked Singer’ season 14. Here are the clues, panel ...

Speaking at the J.P. Morgan conference, CEO David Ricks said he anticipates a “rapid review” for orforglipron that's ...

Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center , positioning the company for ...

A more detailed review of data by the FDA showed that GLP-1 drugs do not increase the risk of suicidal ideation or behavior.